ZA94392B - Internal radiation damage - Google Patents

Internal radiation damage

Info

Publication number
ZA94392B
ZA94392B ZA94392A ZA94392A ZA94392B ZA 94392 B ZA94392 B ZA 94392B ZA 94392 A ZA94392 A ZA 94392A ZA 94392 A ZA94392 A ZA 94392A ZA 94392 B ZA94392 B ZA 94392B
Authority
ZA
South Africa
Prior art keywords
radiation damage
internal radiation
internal
damage
radiation
Prior art date
Application number
ZA94392A
Other languages
English (en)
Inventor
David Frederick Horrobin
Catherine Ann Scott
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of ZA94392B publication Critical patent/ZA94392B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA94392A 1993-01-26 1994-01-20 Internal radiation damage ZA94392B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939301446A GB9301446D0 (en) 1993-01-26 1993-01-26 Internal radiation damage

Publications (1)

Publication Number Publication Date
ZA94392B true ZA94392B (en) 1994-09-01

Family

ID=10729293

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA94392A ZA94392B (en) 1993-01-26 1994-01-20 Internal radiation damage

Country Status (12)

Country Link
US (2) US5583159A (fr)
EP (1) EP0609064A1 (fr)
JP (1) JPH06279277A (fr)
KR (1) KR940018089A (fr)
CN (1) CN1104496A (fr)
AU (1) AU673868B2 (fr)
CA (1) CA2114047A1 (fr)
GB (1) GB9301446D0 (fr)
NO (1) NO940266L (fr)
NZ (1) NZ250757A (fr)
RU (1) RU94002337A (fr)
ZA (1) ZA94392B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9621373D0 (en) * 1996-10-14 1996-12-04 Scotia Holdings Plc Fatty acid treatment
WO1999061182A2 (fr) * 1998-05-28 1999-12-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Systeme stratifie servant a proteger des metaux legers et des alliages legers contre la corrosion
GB0016045D0 (en) * 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
US20020188024A1 (en) * 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
CA2439293A1 (fr) 2001-03-05 2002-09-12 Stephen P. Ernest Formulation enterale
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
FI20060154A7 (fi) 2003-08-18 2006-05-11 Btg Int Ltd Neurogeneratiivisten tilojen hoito
US7537572B2 (en) * 2004-10-22 2009-05-26 General Patent, Llc Treatment or pre-treatment for radiation/chemical exposure
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
GB0504362D0 (en) 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
WO2012087113A1 (fr) 2010-12-24 2012-06-28 N.V. Nutricia Comprimé nutritionnel amélioré
US20130224281A1 (en) * 2011-04-07 2013-08-29 United States Of America As Represented By The Administrator Of The National Aeronautics & Space Method and composition for ameliorating the effects for a subject exposed to radiation or other sources of oxidative stress
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
US8728546B1 (en) 2013-03-15 2014-05-20 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer, cardiovascular diseases and inflammation
JP2016538288A (ja) 2013-11-15 2016-12-08 ディグニティ サイエンシス リミテッド 多価不飽和ヒドロキシ脂肪酸の薬学的に許容される塩
US9682055B2 (en) * 2014-06-04 2017-06-20 Dignity Sciences Limted Pharmaceutical compositions comprising DGLA and use of same
MA47141A (fr) 2015-05-13 2019-11-06 Ds Biopharma Ltd Compositions comprenant du15-oxo-epa ou du 15-oxo-dgla et leurs procédés de préparation et d'utilisation
ES2851525T3 (es) 2015-07-21 2021-09-07 Afimmune Ltd Composiciones que comprenden 15(S)-HEPE para su uso en la sensibilización de las células cancerosas a la radioterapia
CA3129008A1 (en) 2015-12-18 2017-06-22 Afimmune Limited Compositions comprising 15-hepe and methods of using the same
WO2018009700A1 (fr) * 2016-07-06 2018-01-11 Waters Technologies Corporation Surveillance de l'exposition au rayonnement et de la radiosensibilité par spectrométrie de masse à ionisation ambiante
US12171728B2 (en) 2018-04-16 2024-12-24 S&R Farmaceutici S.P.A. Mixture of resveratrol supported on metal hydroxide and non-supported pure resveratrol for treating female fertility
RU2734243C1 (ru) * 2019-07-23 2020-10-13 федеральное государственное бюджетное научное учреждение "Федеральный центр токсикологической, радиационной и биологической безопасности" (ФГБНУ "ФЦТРБ-ВНИВИ") Способ лечения радиационных поражений организма
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2134782B (en) * 1982-09-22 1987-03-04 Sentrachem Ltd Anti-cancer compositions containing higher fatty acids
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments
CA1334006C (fr) * 1987-01-19 1995-01-17 Elisabeth Papaconstantin Compositions cosmetiques et dermatologiques contenant un extrait de marianum silybum riche en silymarine associe a des acides gras essentiels
EP0289204B1 (fr) * 1987-04-27 1991-07-17 Efamol Holdings Plc Compositions pharmaceutiques contenant des sels de lithium
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
US5059622A (en) * 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
GB8920228D0 (en) * 1989-09-07 1989-10-18 Efamol Holdings Fatty acid therapy
US5271925A (en) * 1990-03-09 1993-12-21 Benjamin Sredni Method for protecting against the effects of radiation which is based on the administration of a selenium or tellurium based compound

Also Published As

Publication number Publication date
CN1104496A (zh) 1995-07-05
JPH06279277A (ja) 1994-10-04
NO940266L (no) 1994-07-27
CA2114047A1 (fr) 1994-07-27
RU94002337A (ru) 1996-08-27
US5663202A (en) 1997-09-02
NZ250757A (en) 1997-06-24
KR940018089A (ko) 1994-08-16
GB9301446D0 (en) 1993-03-17
AU673868B2 (en) 1996-11-28
US5583159A (en) 1996-12-10
NO940266D0 (no) 1994-01-25
EP0609064A1 (fr) 1994-08-03
AU5395894A (en) 1994-08-04

Similar Documents

Publication Publication Date Title
ZA94392B (en) Internal radiation damage
AU122792S (en) Engine
GB9403316D0 (en) Set-associative memory
DE59407177D1 (en) 2-fluorcycloyhexen-derivate
GB9311415D0 (en) Imaging arrangements
GB9318205D0 (en) Engine
AU120746S (en) Case
AU122479S (en) Label-printer
GB2279110B (en) An engine
GB9306776D0 (en) Fingerpring imaging
GB2281373B (en) Heat shield
GB2276868B (en) Cosmetic-holder case
DE59407310D1 (en) Phenylazotriazolopyridinfarbstoffe
GB2278313B (en) Protective structure
DE59403125D1 (en) Hohlleitermultiplexer/-demultiplexer
GB9319454D0 (en) Fuel
AU120264S (en) Pod
AU120265S (en) Pod
CA73639S (en) Handstamp
CA72257S (en) Floorstand
HU9302215D0 (en) An environment-sparing procedure
PL300726A1 (en) Radiator
GB9307073D0 (en) Engine
IL107078A0 (en) Engine
PL300438A1 (en) Engine